MU (Micron Technology): Decision Memo, 2026-11-18
Education, not personalized financial advice. Every number below comes from the specialist reports or the facts block. Where data is missing, I say "unknown".
Bottom line
- Long-term investing: WAIT. No position now. At $701.28 the stock trades roughly 10% above the Fundamental analyst's probability-weighted value of about $630. That leaves no margin of safety. The cheap-looking multiples (trailing P/E 9.4, forward P/E 3.4) probably reflect peak-cycle profits, not a bargain. The analyst's patience zone is $350–500.
- Swing trading: NO TRADE. The chart is in a medium- and short-term downtrend. It passes only 4 of 8 Trend Template checks and sits in Weinstein Stage 1/3. There is no valid long setup. A short on a failed bounce is conceptually possible, but the stock's daily swings are too wide for a $50 risk budget.
- Day trading: NO TRADE. the risk review rejected the only proposal, a next-session VWAP rejection short. Its reward-to-risk was 1.0 against a 1.5 minimum, and the stock is not "in play" (RVOL 1.3). Today's session is nearly over.
- Options: NO TRADE. the risk review rejected the bear put spread. Its $465 maximum loss is far above the $100 options budget, and a budget override is not approved.
- Single most important risk: memory profits are at a cyclical extreme. Gross margin is 80.7%, versus −9.1% in FY2023. If the cycle turns, earnings could fall by a large multiple. The first hard test is earnings on 2026-12-23. For traders, the same risk shows up as gap risk: ATR (average true range, the typical daily move) is 8.21% of price, and the worst earnings move was −16.18%.
Long-term investment view
Stance: Neutral. Wait for price or evidence. The investing horizon rests mainly on fundamentals, forensic accounting and macro. None of these three lenses is bullish at today's price.
1. Is it a great business right now? Yes, but at a cyclical peak. - FY2026 revenue was $133.2B, up 256% from $37.4B. - Gross margin is 80.7% and operating margin is 74.6%. - ROIC (return on invested capital) is 84.7% against a WACC (the company's cost of capital) of 13.0%. That means it currently creates a great deal of value. - The history matters, though. FY2023 operating margin was −34.8% and FY2024 was 5.2%. A durable moat normally needs high returns sustained across a full cycle, and this record does not show that yet. - This is the classic base-rate question: how often do memory makers hold peak margins? The specialists did not supply a base rate, so it is unknown. The history above suggests it is low.
2. Is the balance sheet safe? Very. - Net cash is about $38.3B (cash $43.4B, debt $5.2B). - Altman Z-score is 11.97, well inside the "safe" zone. Piotroski F-Score is a perfect 9/9. - Free cash flow (FCF) was $58.96B, a 7.43% FCF yield. - Bankruptcy risk is not the issue. Earnings risk is.
3. What is priced in? - A forward P/E of 3.4 against a next-quarter EPS estimate of $38.29 tells you the market does not believe current earnings will last. That is the "peak-earnings trap" logic. - The 45 sell-side analysts disagree with the market. Their rating is strong_buy, with a mean target of $1,562 (+123%). - The Fundamental analyst sits in between. A normalized-earnings model, which assumes mid-cycle FCF of roughly 25–40% of peak, gives:
| Scenario | Value | Probability |
|---|---|---|
| Bear | $300 | ~30% |
| Base | $600 | ~45% |
| Bull | $1,100 | ~25% |
| Expected value | ≈ $630 |
- For comparison, the mechanical DCF (discounted cash flow model) range is $707 / $1,209 / $1,659. It starts from peak FCF, so I give it little weight. Note that even its bear case sits right at today's price.
4. Forensic check: WATCH, not RED FLAG. - The Beneish M-Score, a screen for possible earnings manipulation, is −0.15. That is above the −1.78 warning line. - However, the score is driven almost entirely by sales growth (SGI 3.563). Accruals are negative (TATA −0.024), which means profits are backed by cash. - Two items deserve follow-up: - Receivables grew 343.85% versus revenue growth of 256.33%. - There were two 8-K Item 5.02 officer changes, plus insider selling of $246.3M with zero insider buys.
5. Macro: HEADWIND. - The 10-year yield is 5.07% and CPI inflation is 4.08%. - Tech (XLK) trails SPY by 6.59 points over 3 months. - MU's beta is 2.4–3.43, meaning it typically moves 2–3x the market. A 5% SPY drop implies roughly −12% to −17% for MU.
Thesis in one sentence: "The market prices Micron as a peak-cycle earner and the sell-side prices a lasting boom. We think the truth is near $630 on probability, so we wait for either a lower price or proof that through-cycle margins are structurally higher."
What would make us bullish: - Evidence that long-term supply agreements or HBM (high-bandwidth memory) contracts keep gross margin above 60% through a downturn. - Price moving into the $350–500 zone, which would create a real margin of safety.
Thesis breakers to write down now, before owning any shares: - Gross margin below about 60% for two straight quarters while DRAM/NAND contract prices fall. - Supply-chain inventory builds or competitor capacity additions. - Hyperscaler capex cuts. - FCF conversion below 50%.
Key unknowns: DRAM/NAND pricing, inventory days, book-to-bill, HBM contract terms, peer multiples. These are the branches of the issue tree that matter most. They are also exactly the ones we lack data on.
Swing trading view
Stance: Bearish bias, but NO TRADE. The swing horizon rests mainly on technicals, flow and the macro regime. The first two lean bearish to neutral, and the third is a headwind.
Trend: - Price is below every key average: - 10-day EMA: 752.77 - 21-day EMA: 803.92 - 200-day SMA: 769.72 - 150-day SMA: 891.41 - 50-day SMA: 925.46 - ADX of 35.5, with −DI at 36.4 versus +DI at 15.0, confirms a strong downtrend. - The base is getting looser, not tighter. Pullback depths went 22% → 29% → 52%. That is the opposite of a constructive base.
Counter-evidence (be honest about it): - The 200-day SMA is still rising, the 1-year return is +190%, and Mansfield relative strength is 3.99. The long-term uptrend is not yet broken. - RSI2, a 2-day oversold gauge, is 8.8. That flags a possible sharp bounce toward 752.77 or 820–823. - The classic RSI2 buy rule requires price above the 200-day SMA, and price is 8.89% below it. So this is not a valid long signal. It is a warning to anyone short.
Flow: - Short interest is only 2.07% of float. There is no squeeze fuel, and shorts are not driving the decline. - Tape-level volume shows mild distribution: CMF20 is −0.128 and OBV is falling. - The 13F data showing institutions adding is about 45 days stale. It predates the recent drop.
The structural problem is sizing. - A sensible swing stop of 1.5–2x ATR is 86–115 points. - A $50 risk budget therefore allows less than one share. - Even with a perfect setup, the stock's volatility is mismatched to this account's risk rules. the risk review also says the regime calls for reduced risk of 0.25–0.5% at most.
What would create a swing trade later (two paths): - (a) Long path: 1. Price holds above 650–651 with tightening ranges and drying volume. 2. Then it closes above the 21-day EMA (~804) and the 823 resistance level. 3. The RS line turns up. 4. SPY reclaims its 50-day average. - (b) Short path (shorts are allowed): a bounce toward 752.77 or 823 fails. This still needs a defined-risk vehicle that fits the budget and has risk review approval.
Trend-following system: Donchian 20/55 is flat. A close below 650 would flip it to a short signal. Note that 651 support is only about 7% below the close, which is less than one ATR away.
Earnings rule: do not hold any swing position through 2026-12-23.
Day trading view (today / next session)
Stance: NO TRADE. The risk review's rejection is final.
Today: - It is about 15:38 ET, with roughly 20 minutes left. The flat-by-close rule applies. - RVOL (relative volume, today's volume versus normal) is 1.3, below the 1.5 "in play" threshold. - Price crossed VWAP (the volume-weighted average price) 26 times. That signals a choppy range day, not a trend day.
Next session: the proposed VWAP-rejection short was rejected for three reasons: 1. Reward-to-risk to the first target was only 1.0, below the 1.5 minimum. 2. The stock was not in play. 3. The account is a $10k margin account under the U.S. pattern-day-trader (PDT) rule. Four or more day trades in five business days triggers restrictions, so each day trade is scarce. A marginal setup should not use one.
What a valid re-submission would need: - A first target worth at least 1.5R. "R" is the amount risked, here $50. - Confirmed RVOL of 1.5 or higher.
Reference levels if you are only watching: - VWAP: 701.96 - Low of day: 687.34 - Previous-day low: 666.88 - High of day: 722.96
Options view
Stance: NO TRADE. The bear put spread is rejected.
Volatility picture: - At-the-money implied volatility (IV) for 30 days is 75.5%. Recent realized volatility (HV20) is 105.8%, so options look cheap versus the last month (ratio 0.71). Against the 60-day realized volatility of 72.5%, they look fair. - The term structure is inverted: 5-day IV is 79.1% versus 70.9% at 58 days. That signals near-term fear or event pricing. - Put skew is steep, 9.3 points at 30 days. Traders are paying up for downside protection. - The options market expects about ±17.5% (±$122.7) over 30 days and about ±8.1% (roughly 644–758) over 5 days. - IV rank is unknown.
Why the spread fails: - Its maximum loss of $465 is more than four times the $100 options budget and about nine times the $50 1R. - The structure was otherwise sensible. It was defined-risk, it expired before earnings (no IV crush), and it bought premium when IV was below realized volatility. - On a $10k account, MU's option prices are simply too large for the risk rules. - All other structures were also ruled out. They were either far over budget, required naked or large cash commitments, or used thin weekly options (median open interest of 60).
Lesson: a good idea is not the same as a good trade for your account.
Where the analysts disagree
1. Fair value: sell-side vs. fundamental vs. market. - Analyst targets: $1,562. Mechanical DCF base case: $1,209. Normalized value: about $630. Price: $701. - Stronger evidence: the normalized approach. For a cyclical business with FY2023 operating margin at −34.8%, extrapolating 80% gross margins is the bigger error risk. - The uniformly bullish sell-side also means there is little variant perception in being bullish. Variant perception means holding a well-founded view that differs from the consensus.
2. Institutions vs. insiders vs. the tape. - 13F filings show 8 of the top 10 holders adding. - Insiders sold $246.3M with zero buys, and the tape shows distribution. - Stronger evidence: the tape and insider data are more recent. 13F data lags about 45 days. Insider selling alone is a weak signal.
3. Long-term trend up vs. short- and medium-term trend down. - The rising 200-day SMA and +190% 1-year return conflict with price below all short-term averages. - Resolution by horizon: for swing and day trading the down-trend dominates. For investing, the long-term trend is less relevant than valuation.
4. Bearish trend vs. oversold bounce risk. - The Technical and Options specialists leaned short. RSI2 of 8.8 and the risk review both flag a violent bounce as a real threat to shorts. - Resolution: the risk review's verdict is final. No short.
5. Forensic flags vs. growth artifact. - The Beneish score and accruals ratio flag "investigate". The specialist judged them mostly a byproduct of hypergrowth and capex. - Status: unresolved until the receivables and DSO data arrive.
6. Data conflict on beta (2.4 vs. 3.43). - This is likely due to different measurement windows. - Either way, MU moves well over twice the market.
What to watch next (catalysts, levels, data)
Earnings, 2026-12-23 (EPS estimate $38.29, revenue estimate $61.83B): - The key line is gross margin, judged against the 60% thesis-break line. - Watch guidance and inventory commentary. - The last earnings beat was only 1.36%, so beats are shrinking. The average earnings-day move is 7.6%.
Price levels: - 650–651 support. A high-volume close below it opens a path toward 435.76 and flips the Donchian system short. - 752.77, the 10-day EMA. This is the first bounce test. - 804 / 820–823, the 21-day EMA and Kijun resistance. A reclaim would neutralize the bearish view.
Macro triggers: - SPY versus its 50-day and 200-day averages. It is only 0.07% above the 200-day. - VIX versus VIX3M (backwardation persisting, or VIX above 30). - The 10-year yield closing above about 5.2%. - The high-yield credit spread moving from 3.43 toward 4.5 percentage points. - A CPI reading above 4.5%.
Forensic follow-ups: - Sizes of the Form 144 filings and whether they are under 10b5-1 plans. - Who left in the 8-K 5.02 changes, especially whether finance leadership was affected. - Receivables footnote and DSO trend. - Any 8-K Item 4.01 or 4.02 filing (auditor change or restatement), which would escalate to a red flag.
Industry data (currently unknown): - DRAM/NAND contract pricing. - Competitor capacity additions. - Hyperscaler capex plans.
Sentiment flips: - Cluster insider buying by several distinct insiders (bullish). - Large top-holder reductions in the next 13F (bearish).